Dr. Lan Peng received her medical degree from Hunan Medical University in China before she moved to the U.S. She worked as a researcher at various institutions including the Harvard Medical School and Thomas Jefferson University before resuming her medical training, which include her residency in pathology at New York University during 2003-2007, a surgical pathology fellowship at MD Anderson Cancer Center in Houston in 2007-2008, and a Liver and GI pathology fellowship at Mount Sinai Medical Center in New York in 2008-2009, where she has received specialty training for liver pathology with Drs. Swan Thung and Isabel Fiel, and GI pathology with Dr. Noam Harpaz.
Before joining the University of Texas Southwestern Medical Center in 2011, Dr. Peng spent two years as an Assistant Professor with the University of Massachusetts Medical School. Her primary clinical focus is transplant liver and gastrointestinal pathology. Her research interests include medical liver disease, inflammatory bowel disease and pancreatic neoplasm.
Dr. Peng is the director of UT Southwestern Medical Center gastrointestinal and liver pathology fellowship.
Dr. Peng is an Editorial Board Member of "Journal of Liver".
- Medical School
- Hunan Medical College (1992)
- New York University Hospital (2007), Pathology
- MD Anderson Cancer Center (2008), Surgical Pathology
- Mount Sinai Medical Center (2009), Liver & Gi Pathology
- Examination of Biopsy, Polypectomy & Resection Specimens
- Histopathologic Diagnosis of Gastrointestinal Cancers & Precursor Lesions
- Molecular Genetic Testing
- Pathologic Analysis & Staging
- Medical Liver Disease
- Pancreatic Neoplasm
- Transplant Liver Pathology
- Pancreatic Neuroendocrine Tumors: Signal Pathways and Targeted Therapies.
- Peng L, Schwarz RE Curr. Mol. Med. 2013 Jan
- Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum.
- Peng L, Schwarz RE Rare Tumors 2012 Apr 4 2 e20
- Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
- Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H Cancer 2011 Dec
- High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.
- Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H Clin. Cancer Res. 2010 Jul 16 14 3734-42
- Novel PRKAR1A gene mutations in Carney Complex.
- Pan L, Peng L, Jean-Gilles J, Zhang X, Wieczorek R, Jain S, Levine V, Osman I, Prieto VG, Lee P Int J Clin Exp Pathol 2010 3 5 545-8
- Vaccination as a triggering event for autoimmune hepatitis.
- Perumalswami P, Peng L, Odin JA Semin. Liver Dis. 2009 Aug 29 3 331-4
- Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.
- Peng L, Wen Y, Han Y, Wei A, Shi G, Mizuguchi M, Lee P, Hernando E, Mittal K, Wei JJ Fertil. Steril. 2009 Jun 91 6 2664-75
- Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
- Ward SC, Chang CY, Peng L, Liu LU Semin. Liver Dis. 2009 May 29 2 233-7
- Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.
- Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF J. Biol. Chem. 2004 Jun 279 25 26475-80
- Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene.
- Anusaksathien O, Laplace C, Li X, Ren Y, Peng L, Goldring SR, Galson DL J. Biol. Chem. 2001 Jun 276 25 22663-74
Targeted gene repair in mammalian cells using chimerical Oligonucleotides.. In Genetic Engineering: Principles and Methods
Kmiec EB, Ye S and Peng L (2001). New York, USA, Springer